Silence Therapeutics (SLN) Superinvestor holders
5 of the superinvestors we track hold Silence Therapeutics (SLN) in their latest 13F filings, $19M in total.
Summary
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $15M, 0.9% of the portfolio.
In their latest quarter: 2 opened a new position, 1 added, 2 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Wilmot Harkey Nantahala Capital Management |
Trimmed | 1,346,731 | $15M | 0.9% | Q2 2026 |
| Alger Fred Alger Management |
New position | 177,000 | $2M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 121,004 | $1M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 72,039 | $790,989 | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
New position | 16,930 | $185,891 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 6 |
| Q1 2026 | 5 |
| Q4 2025 | 4 |
| Q3 2025 | 4 |
| Q2 2025 | 3 |
| Q1 2025 | 5 |
| Q4 2024 | 5 |
| Q3 2024 | 5 |
Questions about Silence Therapeutics
Which superinvestors own Silence Therapeutics?
5 of the superinvestors we track hold Silence Therapeutics (SLN) in their latest 13F filings, $19M in total. Wilmot Harkey, Alger, Two Sigma, Paul Marshall, Jim Simons.
Who is the largest superinvestor holder of SLN?
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $15M, 0.9% of the portfolio.
From Silence Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.